Clinical trial
Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and…
NCT00169182 · Groupe Oncologie Radiotherapie Tete et Cou, Other · Completed
Key facts
| NCT number | NCT00169182 |
|---|---|
| Title | Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma |
| Official title | Randomized Study Comparing Induction Chemotherapy With Docetaxel, Cisplatin, 5FU Versus Cisplatin, 5 FU in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma |
| Lead sponsor | Groupe Oncologie Radiotherapie Tete et Cou, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Larynx Cancer, Hypopharynx Cancer |
| Intervention type | Drug |
| Interventions | DOCETAXEL, Cisplatin, 5-Fluoro-3-Pyridinecarboxylic Acid |
| Enrollment | 220 |
| Start date | Dec 15, 2001 |
| Primary completion | Apr 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 15, 2019 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: